最近活动 最近活动
Activities
Home > Activities > ActivitiesMore

China Biologics Formulation&Analysis Summit

2018.9/20-21

未标题-2.png


The 2nd Annual Biologics Formulation and Analysis Summit

举办时间:2018.Sep.20-21

举办地点Shanghai·China·Wyndham Bund East Shanghai Hotel

主办单位中国药学会(制药工程专业委员会

主办单位:百世传媒 | Best Media

   2017 Sponsors   


微信截图_20180606150828.png

  2018 Speakers    

嘉宾.jpg

  Meeting Agenda  

微信截图_20180627103011.png

Conference Day One

Advances in Characterization Methods & biologic formulation development strategy

08:30 Understanding the Importance of Formulation Development for the Success Development of Biological Product

Li Shi,CEO,Shanghai Zerun Biotechnology Co., Ltd

09:30 Repositioning Formulation and Delivery in R&D of Biological Drug Product

Jun Xiang, President, China Gateway Biologics (Shanghai) Co. Ltd.

10:30 Coffee Break and Network opportunities 

11:00 Panel Discussion: New Approaches to Evaluate the CQA and Stability of Protein Therapeutics

Feng He, Chief Operating Officer, Escugen Bio                                       

Minmin Qin, Senior Vice President, Head of CMC, Harbour BioMed

12:00 Networking Lunch and Group Photo-Taking Session

13:00 Biologics Pre-treatment and Using High Throughput Method to Evaluate Formulation Stability

14:00 Multi-Attribute Method (MAM) for Improving Product and Process Development

15:00 Coffee Break and Network opportunities

15:30 Develop Hypodermic High Concentration Protein Injections

E Guan, Director of Drug Delivery and Device Development, MedImmune

16:30 Explore mAb drug’s Quality and Testing Standard and Process Optimization

Julie Wei, Director of Analytical and Formulation Development, Just Biotherapeutics 

17:30 End of Conference Day one

微信截图_20180627104034.png

Conference Day Two

Analytical method development, qualification, and validation

08:30 How to Leverage Advanced Analytical Technologies to Develop Better Formulations Faster While Reducing Resource Requirements

Danny K. Chou, President, Compassion Bio solution

09:30 Analytical Method Development and Validation for Therapeutic Proteins 

Krishna Menon, Senior Science ad Standards Liaison, Global Biologics, USP

10:30 Coffee Break and Network opportunities

11:00 Phase Specific Test Method Lifecycle and Lab Quality Practices from R&D to GMP

Chloe Liu, SVP, Bio-Thera (Guangzhou) Solutions, Ltd

12:00 Networking Lunch and Group Photo-Taking Session

Characterizing Protein Aggregates & Impurities from early stage development to manufacturing 

13:00 Factors Influencing Bio therapeutic Monoclonal Antibody Aggregation

Guangliang Greg Pan, SVP, Technical Operations/CMC,MABSPACE Biosciences (Suzhou) Co., Ltd

14:00 Polysorbate Degradation in Biopharmaceutical Formulations: Mechanism, Analysis and Particle Characterizatio 

Kesuo Fan, VP of pharmaceutical Sciences, Gmax Biopharma LLC

15:00 Coffee Break and Network opportunities

15:30 Investigation of micro particles generated by manufacturing processes and container

Zaiqing Wen, Vice President,Shanghai CMC Operation,Generon

16:30 Comparison of Aggregation Propensity and Biophysical Properties of Monoclonal Antibody and ADCs

17:30 The end of the conference

微信截图_20180627104034.png

Post conference workshop

09:00 Introduction to Biologics Formulation and Delivery

Danny K. Chou, President, Compassion Bio solution

12:00 The End of Workshop

Next: 没有了

Down: Drug Delivery & Formulation Asia Summit